Next Generation Biologics Market Analysis by Type (Regenerative Medicine, Antibodies, Insulin, Growth Hormones), by Application (Scientific Research, Medical), and by Region - Forecast to 2029

Request Sample Page

The global market size for next generation biologics products is estimated to be USD 5,981.6 million in 2021 and is expected to witness a CAGR of 8.85% during the forecast period. Rising demand for ADCs, technological advancements, growing reimbursement support, and escalating investment in R&D are the major factors driving the global next generation biologics market. However, various factors such as complexities in manufacturing of biologics, complicated regulatory framework, and difficulties in patient recruitment for conducting clinical trials, high cost, and failure rate in clinical trials are hindering the market growth.

Global Next Generation Biologics Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Type

On the basis of type, the global market was segmented into antibodies, regenerative medicine, insulin, growth hormones, and others. In 2021, the regenerative medicine segment accounted for the largest share due to increasing demand for tissue-engineered and application of stem cell products for the treatment of rare diseases. The antibodies segment is anticipated to grow at a lucrative CAGR during the forecast period owing to growing government funding’s in R&D, increasing focus on cell therapy products, and occurrence of chronic disease.

By Application

On the basis of the application, the market was segmented into scientific research, medical, and others. In 2021, scientific research segment accounted for the significant revenue share due to expanding r&d activities in biotechnology companies and academic institutes. The medical application segment is anticipated to grow at the fastest CAGR during the forecast period. This is owing to the rising initiatives taken by private and public organizations for adoption of advanced technology.

Regional Insights

In 2021, North America dominated the global next generation biologics market owing to the presence of prominent players in the region, highly advanced infrastructure, and government support. Asia Pacific market is the anticipated to grow at the fastest CAGR during the forecast period due to high growth opportunities, strengthening economy and booming healthcare sector in the region.

Competitor Insights

Some of the major companies in the next generation biologics market Novo Nordisk (Denmark), Biogen Inc. (U.S.), Roche Holding AG (Switzerland), Pfizer Inc. (U.S.), Molecular Partners AG (Switzerland), Sanofi S.A. (France), Eli Lilly and Company (U.S.), Mitsubishi Group (Japan), AbbVie Inc. (U.S.), and Bayer AG (Germany). Investment in R&D, novel product launches, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The next generation biologics market report is categorized into the following segments and subsegments:

Next Generation Biologics Market, By Type (Revenue, 2021-2029, USD Million)

  • Regenerative medicine
  • Antibodies
  • Growth hormones
  • Insulin
  • Other

Next Generation Biologics Market, By Application (Revenue, 2021-2029, USD Million)

  • Scientific Research
  • Medical
  • Other

Next Generation Biologics Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Next Generation Biologics Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Next Generation Biologics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Next Generation Biologics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Next Generation Biologics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Type
    1. Regenerative medicine
      1. Regenerative medicine Market Forecast, 2021-2029 (USD Million)
    2. Antibodies
      1. Antibodies Market Forecast, 2021-2029 (USD Million)
    3. Growth hormones
      1. Growth hormones Market Forecast, 2021-2029 (USD Million)
    4. Insulin
      1. Insulin Market Forecast, 2021-2029 (USD Million)
    5. Other
      1. Other Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Scientific Research
      1. Scientific Research Market Forecast, 2021-2029 (USD Million)
    2. Medical
      1. Medical Market Forecast, 2021-2029 (USD Million)
    3. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Next Generation Biologics Market
    1. North America Next Generation Biologics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. S. Next Generation Biologics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Canada Next Generation Biologics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Europe Next Generation Biologics Market
    1. Europe Next Generation Biologics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Germany Next Generation Biologics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. UK Next Generation Biologics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. France Next Generation Biologics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Spain Next Generation Biologics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Italy Next Generation Biologics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Europe Next Generation Biologics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Asia Pacific Next Generation Biologics Market
    1. Asia Pacific Next Generation Biologics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Japan Next Generation Biologics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. China Next Generation Biologics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. India Next Generation Biologics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. South Korea Next Generation Biologics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Next Generation Biologics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Next Generation Biologics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Latin America Next Generation Biologics Market
    1. Latin America Next Generation Biologics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Brazil Next Generation Biologics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Mexico Next Generation Biologics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Argentina Next Generation Biologics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Rest of Latin America Next Generation Biologics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. MEA Next Generation Biologics Market
    1. MEA Next Generation Biologics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. GCC Next Generation Biologics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. South Africa Next Generation Biologics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Rest of MEA Next Generation Biologics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Novo Nordisk (Denmark)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    2. Biogen Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    3. Roche Holding AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    4. Pfizer Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    5. Molecular Partners AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    6. Sanofi S.A. (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    7. Eli Lilly and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    8. Mitsubishi Group (Japan
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    9. AbbVie Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    10. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports